CXCL9/MIG Polyclonal Antibody bs-2551R from Bioss Inc.

Product Specs
ItemCXCL9/MIG Polyclonal Antibody
CompanyBioss Inc.
Price $375.00Supplier Page View Company Product Page
Catalog Numberbs-2551R
Molecular Weight14kDa
ImmunogenKLH conjugated peptide, human CXCL9
IsotypeIgG
Conjugate/TagUnconjugated
ClonalityPolyclonal
Antibody TypePrimary Antibody
ReactivityRat, Mouse, Pig
Quantity100ul, 20uL
Format0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol
ApplicationsIHC, WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), IHC-P, WB
TargetCXCL9/MIG
HostRabbit
Concentration1ug/ul
NCBI Gene AliasesSCYB9, crg-10, CMK, MIG, Humig
NCBI Full Gene NameC-X-C motif chemokine ligand 9
Tissueliver, Liver, intestines, skin

Add to Compare List

Bioss Inc.

300 Tradecenter Drive

Suite 4610

Woburn, MA 01801

United States

Phone: 800.501.7654 (Toll free)
Phone: +1.781.569.5821 (International)

Email: info@biossusa.com
orders@biossusa.com
support@biossusa.com
sales@biossusa.com

Company Profile

Website: www.biossusa.com

(1) EZH2 elicits CD8(+) T-cell desert in esophageal squamous cell carcinoma via suppressing CXCL9 and dendritic cellsCommunications biologyDecember 19, 2024Zhu CY, Zhai TT, Su M, Pan HC, Tang Q, Huang BH, Chi XR, Li N, Xie LH, Qiu SQ, et al.also used for dual immunofluorescent staining. The antibody combination of rabbit anti-CXCL9 (1:100, bs-2551R, Bioss, Beijing, China) or rabbit anti-CXCR7 (1:100, bs-1305R, Bioss, Beijing, China) with mouse anti-human

(2) Leveraging MRI radiomics signature for predicting the diagnosis of CXCL9 in breast cancerHeliyonOctober 15, 2024Liping Yan, Yuexia Chen, Jianxin Hehigh-pressure steam treatment and then blocked with 10 % bovine serum. Rabbit anti-human CXCL9(Bioss bs-2551R) antibody was added to the slices and incubated overnight. The next day, HRP-labeled secondary antibodies

(3) Macrophages mediate psoriasis via Mincle-dependent mechanism in miceCell death discoveryApril 28, 2023Tan RZ, Zhong X, Han RY, Xie KH, Jia J, Yang Y, Cheng M, Yang CY, Lan HY, Wang L.Cell Signaling Technology), keratin-17 (17516-1-AP, Proteintech), Integrin β1 (bs-0486R, Bioss), CXCL9 (bs-2551R, Bioss) primary antibody (dilution ratio 1:1,000) were added and incubated overnight at 4 °C. After

(4) Identification of Genes Potentially Associated with Melanoma Tumorigenesis Through Co-Expression Network AnalysisInternational Journal of General MedicineNovember 19, 2021Xiuyun Xuan, Yuqi Wang, Yanhong Sun, Changzheng Huangantibody (bs-2475R, Bioss, China), anti-CCL5 antibody (bs-1324R, Bioss, China), anti-CXCL9 antibody (bs-2551R, Bioss, China) and anti-CXCL10 (bs-1502R, Bioss, China) at 4°C overnight. After being washed with PBS

(5) Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironmentCancer Cell InternationalJuly 28, 2021Weina Kong, Gang Zhao, Haixia Chen, Weina Wang, Xiaoqian Shang, Qiannan Sun, Fan Guo, Xiumin Maincubated with 10% normal goat serum for 40 min. Primary antibodies composed of rabbit anti-CXCL9 antibody (bs-2551R [Bioss], 1:100), rabbit anti-CXCL10 antibody (bs-1502R [Bioss], 1:150), rabbit anti-CXCL11 antibody

(6) Cordycepin Attenuates IFN-γ-Induced Macrophage IP-10 and Mig Expressions by Inhibiting STAT1 Activity in CFA-Induced Inflammation Mice ModelInflammationApril 1, 2020Yang R, Wang X, Xi D, Mo J, Wang K, Luo S, Wei J, Ren Z, Pang H, Luo Y.

(7) Delay in hepatocyte proliferation and prostaglandin D2 synthase expression for cholestasis due to endotoxin during partial hepatectomy in ratsMolecular medicine reportsNovember 1, 2019Wakasa Y, Kimura N, Yamada T, Shimizu T, Hakamada K, Tsuchida S.Inc.), anti-CD 163 antibody (sc-58965; 1:500, Santa Cruz Biotechnology, Inc.), anti-Cxcl9 antibody (bs-2551R; 1:500, BIOSS Inc.), and anti-Ptgds2 antibody (PA 5-43217; 1:500, Invitrogen; Thermo Fisher Scientific,

(8) Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillationLaboratory animal researchMarch 1, 2018Lee SY, Cho JH, Cho SS, Bae CS, Kim GY, Park DH.Abcam, Cambridge, UK), CCL-2 (PAB16617; Abnova, Taipei, Taiwan), CXCL-1 (PAB8798,; Abnova), CXCL-9 (bs-2551R; Bioss, Woburn, MA, USA), CXCL-10 (bs-1502R; Bioss), and CXCL-11 (bs-2552R; Bioss). The slides were

(9) Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasiaArch Dermatol ResMay 1, 2017Shimoura N, Nagai H, Fujiwara S, Jimbo H, Yoshimoto T, Nishigori C.

(10) CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitmentScientific reportsNovember 3, 2015Zhang QQ, Hu XW, Liu YL, Ye ZJ, Gui YH, Zhou DL, Qi CL, He XD, Wang H, Wang LJ.for WB) was obtained from Abcam (Cambridge, UK); rabbit anti-IFN-γ (bs-0480R), rabbit anti-CXCL-9 (bs-2551R) (both diluted at 1:500 for WB), rabbit anti-CD11b (bs-1014R) and rabbit anti-Gr-1 (bs-2576R, diluted

(11) Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophagesJournal of hepatologyOctober 1, 2015Yada A, Iimuro Y, Uyama N, Uda Y, Okada T, Fujimoto J.

(12) Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like DiseaseCancer immunology researchAugust 1, 2015Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW.

(13) Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecanOncology reportsMay 1, 2015Sawano T, Shimizu T, Yamada T, Nanashima N, Miura T, Morohashi S, Kudo D, Hui FM, Kijima H, Hakamada K, et al.antibody from Santa Cruz Biotechnology (sc-58965) (Santa Cruz, CA, USA), anti-Cxcl9 antibody from Bioss (bs-2551R) (Boston, MA, USA), anti-cytokeratin 19 antibody from Bioworld Technology, Inc. (BS3540) (St. Louis

(14) Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol dietBMC genomicsFebruary 6, 2015Cai Z, Jiang X, Pan Y, Chen L, Zhang L, Zhu K, Cai Y, Ling Y, Chen F, Xu X, et al.following primary antibodies: anti-CCL2 (1:100; ab7814, Abcam, Cambridge, MA, USA), anti-CXCL9 (1:50; bs-2551R, Bioss, Beijing, China), and anti-IRF7 (1:250; bs-2994R, Bioss). Thereafter, the sections were rinsed

Be the First to Write a Review!

WB

CXCL9/MIG Polyclonal Antibody

CXCL9/MIG Polyclonal Antibody from Bioss Inc.

Description

Bioss Inc.

Citations (14)

Reviews

CXCL9/MIG Polyclonal Antibody from Bioss Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map